Chymotrypsin family serine proteases play essential roles in key biological and pathological processes and are frequently targets of drug discovery efforts. This large enzyme family is also among the most advanced model systems for detailed studies of enzyme mechanism and structure/function relationships. Productive interactions between these enzymes and their substrates are widely believed to mimic the "canonical" interactions between serine proteases and "standard" inhibitors observed in numerous protease-inhibitor complexes. To test this central hypothesis we have synthesized and characterized a series of peptide analogs, based on model substrates and inhibitors of trypsin, that contain unnatural main chains. These results call into question a long accepted theory regarding the interaction of chymotrypsin family serine proteases with substrates and suggest that the canonical interactions observed between these enzymes and standard inhibitors may represent nonproductive rather than productive, substrate-like interactions.The chymotrypsin family of serine proteases contains many members, such as thrombin (1, 2), factor VII (3, 4), protein C (5), tissue-type plasminogen activator (6 -8), urokinase plasminogen activator (9), snake (10 -13), and easter (11)(12)(13)(14)(15), that play essential roles in important biological and pathological processes including embryonic development, the formation and dissolution of blood clots, angiogenesis, and tumor invasion and metastasis (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15). This large enzyme family is also among the most extensively investigated and thoroughly characterized model systems for the detailed study of enzyme mechanism and structure/function relationships (16 -20).The three-dimensional structures of numerous complexes between a chymotrypsin family enzyme and a peptide or proteinaceous inhibitor have been solved, and these structures have provided many important insights into the mechanism and structure/function relationships of serine proteases (21,22). The majority of these protein-protein complexes contain inhibitors known as standard inhibitors because they share a common, standard mechanism of action (22, 23). To date, more than 10 different families of standard mechanism protease inhibitors have been characterized (22, 23). Although they exhibit a similar mechanism of inhibition of serine proteases, neither the primary sequences nor the three-dimensional structures of these families exhibit homology to one another (21,22).Despite their unrelated three-dimensional structures, the details of the interaction of the reactive center loops of standard inhibitors from different gene families with the active site cleft of chymotrypsin family enzymes share remarkable similarities (21, 22). For example, the P3-P3Ј (Schecter and Berger nomenclature (24)) residues of the reactive center loop of standard inhibitors, both as free inhibitors and in complexes with target serine proteases, assume a virtually identical main chain conformation, which has been terme...